Literature DB >> 17426594

Dopamine D2 receptor stimulation promotes the proliferation of neural progenitor cells in adult mouse hippocampus.

Takeshi Hiramoto1, Yasunari Kanda, Yasushi Satoh, Kunio Takishima, Yasuhiro Watanabe.   

Abstract

We initially examined the effects of apomorphine in vitro using mouse embryonic and adult neural progenitor cells. The effects of apomorphine treatment led to dose-dependent increases in the number of embryonic and adult neural progenitor cells, and dopamine D2 receptor antagonist treatment significantly reduced the increases induced by apomorphine. Next, we investigated the effects of apomorphine in vivo in the adult mouse hippocampus. The effects of single-dose apomorphine administration led to an increase of approximately 30% in the number of bromodeoxyuridine-positive cells in the dentate gyrus. Moreover, the chronic apomorphine administration induced an increase in the number of bromodeoxyuridine-positive cells by about 30%. Thus, we suggest that the stimulation of dopamine D2 receptors increases the proliferation of neural progenitor cells both in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426594     DOI: 10.1097/WNR.0b013e3280bef9d3

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

Review 1.  Targeting the hippocampal mossy fiber synapse for the treatment of psychiatric disorders.

Authors:  Katsunori Kobayashi
Journal:  Mol Neurobiol       Date:  2009-01-08       Impact factor: 5.590

2.  Modulation of Postnatal Neurogenesis by Perinatal Asphyxia: Effect of D1 and D2 Dopamine Receptor Agonists.

Authors:  A Tapia-Bustos; R Perez-Lobos; V Vío; C Lespay-Rebolledo; E Palacios; A Chiti-Morales; D Bustamante; M Herrera-Marschitz; P Morales
Journal:  Neurotox Res       Date:  2016-09-16       Impact factor: 3.911

3.  Tbx1: identification of a 22q11.2 gene as a risk factor for autism spectrum disorder in a mouse model.

Authors:  Takeshi Hiramoto; Gina Kang; Go Suzuki; Yasushi Satoh; Raju Kucherlapati; Yasuhiro Watanabe; Noboru Hiroi
Journal:  Hum Mol Genet       Date:  2011-09-09       Impact factor: 6.150

4.  Long-term administration of the dopamine D3/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain.

Authors:  Olga Chernoloz; Mostafa El Mansari; Pierre Blier
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

5.  Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine.

Authors:  Katsuaki Suzuki; Kyoko Okada; Tomoyasu Wakuda; Chie Shinmura; Yosuke Kameno; Keiko Iwata; Taro Takahashi; Shiro Suda; Hideo Matsuzaki; Yasuhide Iwata; Kenji Hashimoto; Norio Mori
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

6.  Obligatory roles of dopamine D1 receptors in the dentate gyrus in antidepressant actions of a selective serotonin reuptake inhibitor, fluoxetine.

Authors:  Takahide Shuto; Mahomi Kuroiwa; Naoki Sotogaku; Yukie Kawahara; Yong-Seok Oh; Jin-Hyeok Jang; Chang-Hoon Shin; Yoshinori N Ohnishi; Yuuki Hanada; Tsuyoshi Miyakawa; Yong Kim; Paul Greengard; Akinori Nishi
Journal:  Mol Psychiatry       Date:  2018-12-10       Impact factor: 15.992

7.  Dopamine signaling impairs ROS modulation by mitochondrial hexokinase in human neural progenitor cells.

Authors:  Gabriela Assis-de-Lemos; Jamila Monteiro; Viviane M Oliveira-Valença; Guilherme A Melo; Ricardo A de Melo Reis; Stevens K Rehen; Mariana S Silveira; Antonio Galina
Journal:  Biosci Rep       Date:  2021-12-22       Impact factor: 3.840

8.  Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes?

Authors:  Paola Morales; Diego Bustamante; Pablo Espina-Marchant; Tanya Neira-Peña; Manuel A Gutiérrez-Hernández; Camilo Allende-Castro; Edgardo Rojas-Mancilla
Journal:  EPMA J       Date:  2011-07-26       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.